A Cross-sectional, comparative study of insight in schizophrenia and bipolar patients in remission

Arul Saravanan Ramachandran, Rajkumar Ramanathan, Samir Kumar Praharaj, Haridas Kanradi, Podila Satya Venkata Narasimha Sharma

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims: To study insight correlates in schizophrenia and bipolar mood disorder in remission among out-patients attending the Psychiatry Department of a Tertiary Care Hospital. Settings and Design: In a cross-sectional, naturalistic study, adult patients with schizophrenia and bipolar mood disorder in remission (n = 80; schizophrenia-40, mania-20, bipolar depression-20) were compared on insight measures and clinical correlates. Materials and Methods: Scale to Assess the Unawareness of Mental Disorders (SUMD) was used as the main tool to assess current and past measures of insight. Hogan's Drug Attitude Inventory was used to assess the drug attitude and compliance. Positive and Negative Symptom Scale for Schizophrenia, Young's Mania Rating Scale, and HAMD were used to rate psychopathology. Clinical Global Improvement was used as a screening tool for remission. Statistical Analysis: For comparison of the three clinical groups, analysis of variance and Chi-square test were used. In the post-hoc analysis, the Ryan-Einot-Gabriel-Welsch test was used to find the group difference. Results: About 40% in the schizophrenia group were unaware of their mental illness as against none in the bipolar group. The awareness of mental disorder for the current period, the awareness of the achieved effects of medications, and the awareness of social consequence was better in the bipolar group. The drug attitude (compliant positive attitude) increased as the SUMD item scale decreased or in other words, as the insight improved. Conclusions: Insight, both current and retrospect, showed significant differences between the schizophrenia and bipolar patients. Insight is significantly correlated with the observed compliance and drug attitude of the patient groups.

Original languageEnglish
Pages (from-to)207-212
Number of pages6
JournalIndian Journal of Psychological Medicine
Volume38
Issue number3
DOIs
Publication statusPublished - 01-05-2016

Fingerprint

Schizophrenia
Bipolar Disorder
Cross-Sectional Studies
Mood Disorders
Mental Disorders
Pharmaceutical Preparations
Compliance
Tertiary Healthcare
Chi-Square Distribution
Psychopathology
Tertiary Care Centers
Psychiatry
Analysis of Variance
Outpatients
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Clinical Psychology

Cite this

Ramachandran, Arul Saravanan ; Ramanathan, Rajkumar ; Praharaj, Samir Kumar ; Kanradi, Haridas ; Narasimha Sharma, Podila Satya Venkata. / A Cross-sectional, comparative study of insight in schizophrenia and bipolar patients in remission. In: Indian Journal of Psychological Medicine. 2016 ; Vol. 38, No. 3. pp. 207-212.
@article{a5f7eb4a3eb84b54982d0efc00c69a00,
title = "A Cross-sectional, comparative study of insight in schizophrenia and bipolar patients in remission",
abstract = "Aims: To study insight correlates in schizophrenia and bipolar mood disorder in remission among out-patients attending the Psychiatry Department of a Tertiary Care Hospital. Settings and Design: In a cross-sectional, naturalistic study, adult patients with schizophrenia and bipolar mood disorder in remission (n = 80; schizophrenia-40, mania-20, bipolar depression-20) were compared on insight measures and clinical correlates. Materials and Methods: Scale to Assess the Unawareness of Mental Disorders (SUMD) was used as the main tool to assess current and past measures of insight. Hogan's Drug Attitude Inventory was used to assess the drug attitude and compliance. Positive and Negative Symptom Scale for Schizophrenia, Young's Mania Rating Scale, and HAMD were used to rate psychopathology. Clinical Global Improvement was used as a screening tool for remission. Statistical Analysis: For comparison of the three clinical groups, analysis of variance and Chi-square test were used. In the post-hoc analysis, the Ryan-Einot-Gabriel-Welsch test was used to find the group difference. Results: About 40{\%} in the schizophrenia group were unaware of their mental illness as against none in the bipolar group. The awareness of mental disorder for the current period, the awareness of the achieved effects of medications, and the awareness of social consequence was better in the bipolar group. The drug attitude (compliant positive attitude) increased as the SUMD item scale decreased or in other words, as the insight improved. Conclusions: Insight, both current and retrospect, showed significant differences between the schizophrenia and bipolar patients. Insight is significantly correlated with the observed compliance and drug attitude of the patient groups.",
author = "Ramachandran, {Arul Saravanan} and Rajkumar Ramanathan and Praharaj, {Samir Kumar} and Haridas Kanradi and {Narasimha Sharma}, {Podila Satya Venkata}",
year = "2016",
month = "5",
day = "1",
doi = "10.4103/0253-7176.183085",
language = "English",
volume = "38",
pages = "207--212",
journal = "Indian Journal of Psychological Medicine",
issn = "0253-7176",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

A Cross-sectional, comparative study of insight in schizophrenia and bipolar patients in remission. / Ramachandran, Arul Saravanan; Ramanathan, Rajkumar; Praharaj, Samir Kumar; Kanradi, Haridas; Narasimha Sharma, Podila Satya Venkata.

In: Indian Journal of Psychological Medicine, Vol. 38, No. 3, 01.05.2016, p. 207-212.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Cross-sectional, comparative study of insight in schizophrenia and bipolar patients in remission

AU - Ramachandran, Arul Saravanan

AU - Ramanathan, Rajkumar

AU - Praharaj, Samir Kumar

AU - Kanradi, Haridas

AU - Narasimha Sharma, Podila Satya Venkata

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Aims: To study insight correlates in schizophrenia and bipolar mood disorder in remission among out-patients attending the Psychiatry Department of a Tertiary Care Hospital. Settings and Design: In a cross-sectional, naturalistic study, adult patients with schizophrenia and bipolar mood disorder in remission (n = 80; schizophrenia-40, mania-20, bipolar depression-20) were compared on insight measures and clinical correlates. Materials and Methods: Scale to Assess the Unawareness of Mental Disorders (SUMD) was used as the main tool to assess current and past measures of insight. Hogan's Drug Attitude Inventory was used to assess the drug attitude and compliance. Positive and Negative Symptom Scale for Schizophrenia, Young's Mania Rating Scale, and HAMD were used to rate psychopathology. Clinical Global Improvement was used as a screening tool for remission. Statistical Analysis: For comparison of the three clinical groups, analysis of variance and Chi-square test were used. In the post-hoc analysis, the Ryan-Einot-Gabriel-Welsch test was used to find the group difference. Results: About 40% in the schizophrenia group were unaware of their mental illness as against none in the bipolar group. The awareness of mental disorder for the current period, the awareness of the achieved effects of medications, and the awareness of social consequence was better in the bipolar group. The drug attitude (compliant positive attitude) increased as the SUMD item scale decreased or in other words, as the insight improved. Conclusions: Insight, both current and retrospect, showed significant differences between the schizophrenia and bipolar patients. Insight is significantly correlated with the observed compliance and drug attitude of the patient groups.

AB - Aims: To study insight correlates in schizophrenia and bipolar mood disorder in remission among out-patients attending the Psychiatry Department of a Tertiary Care Hospital. Settings and Design: In a cross-sectional, naturalistic study, adult patients with schizophrenia and bipolar mood disorder in remission (n = 80; schizophrenia-40, mania-20, bipolar depression-20) were compared on insight measures and clinical correlates. Materials and Methods: Scale to Assess the Unawareness of Mental Disorders (SUMD) was used as the main tool to assess current and past measures of insight. Hogan's Drug Attitude Inventory was used to assess the drug attitude and compliance. Positive and Negative Symptom Scale for Schizophrenia, Young's Mania Rating Scale, and HAMD were used to rate psychopathology. Clinical Global Improvement was used as a screening tool for remission. Statistical Analysis: For comparison of the three clinical groups, analysis of variance and Chi-square test were used. In the post-hoc analysis, the Ryan-Einot-Gabriel-Welsch test was used to find the group difference. Results: About 40% in the schizophrenia group were unaware of their mental illness as against none in the bipolar group. The awareness of mental disorder for the current period, the awareness of the achieved effects of medications, and the awareness of social consequence was better in the bipolar group. The drug attitude (compliant positive attitude) increased as the SUMD item scale decreased or in other words, as the insight improved. Conclusions: Insight, both current and retrospect, showed significant differences between the schizophrenia and bipolar patients. Insight is significantly correlated with the observed compliance and drug attitude of the patient groups.

UR - http://www.scopus.com/inward/record.url?scp=84973334074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973334074&partnerID=8YFLogxK

U2 - 10.4103/0253-7176.183085

DO - 10.4103/0253-7176.183085

M3 - Article

AN - SCOPUS:84973334074

VL - 38

SP - 207

EP - 212

JO - Indian Journal of Psychological Medicine

JF - Indian Journal of Psychological Medicine

SN - 0253-7176

IS - 3

ER -